BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 38487261)

  • 1. Uridine and its role in metabolic diseases, tumors, and neurodegenerative diseases.
    Yang Y; Ye Y; Deng Y; Gao L
    Front Physiol; 2024; 15():1360891. PubMed ID: 38487261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.
    Liu X; Cai YD; Chiu JC
    J Biol Chem; 2024 Feb; 300(2):105616. PubMed ID: 38159854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

  • 5. A nexus of lipid and
    Lockridge A; Hanover JA
    Front Endocrinol (Lausanne); 2022; 13():943576. PubMed ID: 36111295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
    Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
    Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a five-enzyme cell-free cascade for the synthesis of uridine diphosphate N-acetylglucosamine.
    Mahour R; Klapproth J; Rexer TFT; Schildbach A; Klamt S; Pietzsch M; Rapp E; Reichl U
    J Biotechnol; 2018 Oct; 283():120-129. PubMed ID: 30044949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
    Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; Quinoñes-Hinojosa A; Yarema KJ
    ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Dysregulation of
    Very N; Vercoutter-Edouart AS; Lefebvre T; Hardivillé S; El Yazidi-Belkoura I
    Front Endocrinol (Lausanne); 2018; 9():602. PubMed ID: 30356686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
    Love DC; Hanover JA
    Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle uridine diphosphate-hexosamines do not decrease despite correction of hyperglycemia-induced insulin resistance in type 2 diabetes.
    Pouwels MJ; Span PN; Tack CJ; Olthaar AJ; Sweep CG; van Engelen BG; de Jong JG; Lutterman JA; Hermus AR
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5179-84. PubMed ID: 12414889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAcylation, a sweet link to the pathology of diseases.
    Nie H; Yi W
    J Zhejiang Univ Sci B; 2019 May; 20(5):437-448. PubMed ID: 31090269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexosamine biosynthesis in keratinocytes: roles of GFAT and GNPDA enzymes in the maintenance of UDP-GlcNAc content and hyaluronan synthesis.
    Oikari S; Makkonen K; Deen AJ; Tyni I; Kärnä R; Tammi RH; Tammi MI
    Glycobiology; 2016 Jul; 26(7):710-22. PubMed ID: 26887390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uridine Metabolism and Its Role in Glucose, Lipid, and Amino Acid Homeostasis.
    Zhang Y; Guo S; Xie C; Fang J
    Biomed Res Int; 2020; 2020():7091718. PubMed ID: 32382566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation.
    Laczy B; Fülöp N; Onay-Besikci A; Des Rosiers C; Chatham JC
    PLoS One; 2011 Apr; 6(4):e18417. PubMed ID: 21494549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein O-GlcNAcylation and the regulation of energy homeostasis: lessons from knock-out mouse models.
    Issad T; Al-Mukh H; Bouaboud A; Pagesy P
    J Biomed Sci; 2022 Sep; 29(1):64. PubMed ID: 36058931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways.
    Ryczko MC; Pawling J; Chen R; Abdel Rahman AM; Yau K; Copeland JK; Zhang C; Surendra A; Guttman DS; Figeys D; Dennis JW
    Sci Rep; 2016 Mar; 6():23043. PubMed ID: 26972830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foetal recapitulation of nutrient surplus signalling by O-GlcNAcylation and the failing heart.
    Packer M
    Eur J Heart Fail; 2023 Aug; 25(8):1199-1212. PubMed ID: 37434410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Energy Metabolism and Hyaluronan Synthesis.
    Caon I; Parnigoni A; Viola M; Karousou E; Passi A; Vigetti D
    J Histochem Cytochem; 2021 Jan; 69(1):35-47. PubMed ID: 32623953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.